According to our latest research, the global spinal surgery device market size reached USD 13.8 billion in 2024, reflecting robust demand across various healthcare settings. The market is expected to grow at a CAGR of 5.7% from 2025 to 2033, reaching a projected value of USD 22.6 billion by 2033. This growth is primarily driven by the increasing prevalence of spinal disorders, technological advancements in surgical devices, and the rising adoption of minimally invasive procedures. As per our comprehensive analysis, the spinal surgery device market is witnessing a paradigm shift, underpinned by significant investments in research and development, as well as evolving patient demographics and clinical needs. https://growthmarketreports.com/report/france-spinal-surgery-device-market-industry-analysis

Top 10 Companies Leading the Platelet-Rich Plasma Market Growth According to a newly published market research report by 24LifeSciences, Global Platelet Rich Plasma (PRP) Market was valued at USD 333 million in 2024 and is projected to reach USD 728 million by 2032, growing at a compound annual growth rate (CAGR) of 12.1% during the forecast period 2025-2032. Platelet Rich Plasma (PRP) is a concentrated autologous blood product containing high levels of platelets and growth factors, derived through centrifugation of whole blood. PRP therapy harnesses the body's natural healing mechanisms to promote tissue regeneration, making it valuable in orthopedic, cosmetic, and dental applications. Its established efficacy in accelerating healing continues to underpin its importance in regenerative medicine and minimally invasive treatments. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/1765/platelet-rich-plasma-prp-market

Injectable Hydrogel Technology Market to Reach USD 66.5 Million by 2031 | Growth Insights According to a newly published market research report by 24LifeSciences, global injectable hydrogel technology market was valued at USD 37.6 million in 2024 and is projected to reach USD 66.5 million by 2031, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2025–2031. Injectable hydrogel technology represents a significant advancement in biomaterial science, featuring highly hydrated, three-dimensional polymer networks that can be administered through minimally invasive injections before undergoing self-gelation or crosslinking within the body. These engineered materials provide exceptional biocompatibility, biodegradability, and tunable mechanical properties that make them particularly valuable for advanced drug delivery systems, tissue engineering applications, and regenerative medicine solutions. The established efficacy of these technologies continues to support their growing importance across multiple medical disciplines including orthopedics, cardiology, and aesthetic medicine. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4911/injectable-hydrogel-technology-market

Global Intracorporeal Shock Wave Lithotripsy Market Forecast 2025 According to a newly published market research report by 24LifeSciences, global intracorporeal shock wave lithotripsy market was valued at USD 394 million in 2024 and is projected to reach USD 569 million by 2031, growing at a compound annual growth rate (CAGR) of 5.4% during the forecast period. Intracorporeal Shock Wave Lithotripsy (ISWL) is a minimally invasive medical procedure used to break down kidney stones, ureteral stones, or bladder stones inside the body using shock waves delivered directly to the stone via an endoscopic device inserted into the urinary tract. Its proven efficacy in stone fragmentation and reduced tissue trauma continues to underpin its importance in urology and minimally invasive surgery. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5146/intracorporeal-shock-wave-lithotripsy-market

What Is the Future of the Epistaxis Balloon Catheter Market? 2025–2032 Outlook According to a newly published market research report by 24LifeSciences, global epistaxis balloon catheter market was valued at USD 79.9 million in 2024 and is projected to reach USD 111 million by 2031, growing at a compound annual growth rate (CAGR) of 5.0% during the forecast period 2025–2031. Epistaxis balloon catheters represent a significant advancement in managing anterior and posterior nasal bleeding, providing a minimally invasive solution that applies controlled pressure to the nasal cavity. These single-use, sterile devices not only stop hemorrhages effectively but also maintain patient comfort, making them increasingly preferred over traditional packing methods. Their growing adoption in emergency departments and specialized ENT practices underscores their critical role in modern hemorrhage control protocols. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5468/epistaxis-balloon-catheter-market

Leading Companies in Catheter Sheath Market to Watch by 2032 According to a newly published market research report by 24LifeSciences, global catheter sheath market was valued at USD 2.1 billion in 2024 and is projected to reach USD 3.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 2025–2032. Catheter sheaths, also known as introducer sheaths, are critical medical devices used to establish and maintain vascular access during minimally invasive procedures. These devices enable the safe insertion of catheters, guidewires, and other interventional tools while minimizing vessel trauma and blood loss. Essential applications span cardiology, radiology, urology, and vascular surgery, with key product variations including standard sheaths, leak-proof sheaths with integrated hemostatic valves, and peel-away sheaths designed for complex device delivery. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/11417/catheter-sheath-market

Hemorrhoids Treatment Market Growth Analysis & Opportunities According to a newly published market research report by 24LifeSciences, global hemorrhoids treatment market was valued at USD 725.8 million in 2024 and is projected to reach USD 1.07 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2032. Hemorrhoids, clinically known as piles, are swollen veins in the lower rectum and anus that cause discomfort, itching, and bleeding. The condition affects nearly 50% of the adult population over age 50 and represents a significant healthcare burden globally. Treatment modalities range from over-the-counter topical preparations to advanced minimally invasive procedures like rubber band ligation, sclerotherapy, infrared coagulation, and surgical interventions. The market's growth is primarily driven by increasing prevalence, aging demographics, and technological advancements favoring less invasive treatment options. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10096/hemorrhoids-treatment-market

Tubular Metal Biliary Stents Market to Reach USD 510 Million by 2034 According to a newly published market research report by 24LifeSciences, global tubular metal biliary stents market is valued at USD 337 million in 2026 and is projected to reach USD 510 million by 2034, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period. Tubular metal biliary stents are self-expanding metallic mesh devices primarily used to maintain bile duct patency in patients suffering from malignant obstructions caused by pancreatic cancer or cholangiocarcinoma, as well as benign strictures. These minimally invasive implants are deployed via endoscopic retrograde cholangiopancreatography (ERCP) procedures to relieve jaundice, prevent life-threatening cholangitis, and significantly improve patients' quality of life. The market is primarily segmented into covered stentswhich feature a polymer membrane to prevent tumor ingrowthand uncovered stents, each offering distinct clinical advantages for specific patient populations. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10403/tubular-metal-biliary-stents-market

What Is Fueling the Global Endovascular Robot Market’s Rapid 17.1% CAGR Expansion? Intel Market Research, the global Endovascular Robot market was valued at USD 1.14 billion in 2026 and is projected to reach USD 3.25 billion by 2034, growing at an impressive CAGR of 17.1% during the forecast period (2026-2034). This exceptional growth is driven by increasing demand for minimally invasive vascular procedures, technological advancements in robotic systems, and the rising prevalence of cardiovascular diseases worldwide. https://www.intelmarketresearch.com/uv-skin-machines-market-30300

Minimally Invasive Cardiac Surgery Instruments Market’s CAGR of 6.8%: Leading Firms According to a newly published market research report by 24LifeSciences, global minimal invasive cardiac surgery instruments market is valued at USD 2.4 billion in 2026 and is projected to reach USD 4.1 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period. Minimally invasive cardiac surgery (MICS) instruments are specialized medical devices designed to perform complex heart surgeries through small incisions, significantly reducing patient trauma compared to traditional open-heart procedures. This category includes robotic-assisted systems, thoracoscopic instruments, and direct minimally invasive tools like specialized retractors, aortic clamps, and high-definition endoscopic cameras. Their implementation enables surgeons to operate with enhanced precision through ports, leading to substantial patient benefits including shorter hospital stays, faster recovery times, reduced blood loss, and improved cosmetic outcomes. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10509/minimal-invasive-cardiac-surgery-instruments-market